MedTrace Logo

Patient Preference Study

NCT00576342 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2014-07-11

No results posted yet for this study

Summary

In this randomized crossover study, patients will receive a single drop of two test articles and assess comfort.

Conditions

Interventions

DRUG

AL-3862+timolol ophthalmic suspension

DRUG

Dorzolamide+timolol ophthalmic solution

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-01-31
Completion
2008-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00576342 on ClinicalTrials.gov